Claudia Seitz

University of Ghent, Faculty of Law

SCHOLARLY PAPERS

3

DOWNLOADS

108

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (3)

1.

Lost on the High Seas without a Safe Harbor or a Shield? Navigating Cross-Border Data Transfers in the Pharmaceutical Sector After Schrems II Invalidation of the EU-US Privacy Shield

European Pharmaceutical Law Review (EPLR), 4(3):153-160
Number of pages: 10 Posted: 28 Jan 2021 Last Revised: 10 Apr 2021
Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), Faculty of Law, University of Copenhagen, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, University of Ghent, Faculty of Law and LML, University of Cambridge
Downloads 108 (340,577)

Abstract:

Loading...

GDPR, Data transfer, Schrems II case, data protection, data security, Privacy Shield, Standard Contractual Clauses (SCCs), pharmaceutical sector

2.

The Legal Dimensions of Big Data, Artificial Intelligence and Machine Learning in Pharmaceutical Innovation (Original Title in Accepted Version): Editorial to Special Issue of the European Pharmaceutical Law Review on 'Big Data, AI & Machine Learning in Pharmaceutial Innovation'

Minssen, T. , & Seitz, C. Editorial European Pharmaceutical Law Review, Volume 3, Issue 4 (2019) pp. 139 - 141 DOI: 10.21552/eplr/2019/4/3
Posted: 18 Aug 2020
Timo Minssen and Claudia Seitz
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and University of Ghent, Faculty of Law

Abstract:

Loading...

3.

The EU-US Privacy Shield Regime for Cross- Border Transfers of Personal Data under the GDPR: What are the legal challenges and how might these affect cloudbased technologies, big data, and AI in the medical sector?

Lexxion, 2020
Posted: 14 Aug 2020
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, University of Ghent, Faculty of Law, LML, University of Cambridge and Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), Faculty of Law, University of Copenhagen

Abstract:

Loading...